SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tema ETF Trust - Tema Space Innovators ETF

The Tema Space Innovators ETF ($NASA) is generating significant buzz as investors look to gain exposure to the broader space economy and high-profile private companies like SpaceX ahead of an anticipated IPO. Community members are actively debating the merits of holding the ETF as a diversified, long-term vehicle versus individual sector plays, with intense interest centered on the fund's specific SpaceX allocation and the momentum building around upcoming aerospace launches.

Momentus, Inc. engages in the provision of in-space infrastructure services. It offers space transportation and in-orbit servicing. The company was founded by Mikhail Kokorich in 2017 and is headquartered in Santa Jose, CA.

Momentus Inc - Ordinary Shares - Class A

Momentus Inc. is trending as investors focus on its role as a key infrastructure partner for SpaceX, with the community actively discussing a recent 9.99% stake acquisition by Citadel and the company's debt-free balance sheet. Market participants are debating the potential for a short squeeze given the stock's low float and the anticipation surrounding the upcoming SpaceX IPO.

Entrepreneurshares Series Trust - ERShares Private-Public Crossover ETF

Investors are flocking to XOVR as a liquid and NAV-aligned vehicle to gain indirect exposure to SpaceX, with ongoing community debate comparing its structure to other SpaceX-exposed funds like DXYZ and ARKVX. The primary catalyst fueling discourse is the highly anticipated prospect of a SpaceX IPO, which traders believe could act as a significant price catalyst for the ETF.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercard is gaining momentum as investors pivot toward durable, cash-generative payment networks while monitoring potential regulatory shifts like credit card interest rate caps. The community remains focused on the company's resilience, its strategic push into AI and blockchain-based infrastructure, and its ability to maintain growth through global transaction volume.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

Groupon is seeing intense community speculation as investors position for a potential short squeeze, fueled by high short interest and aggressive company share buybacks aimed at tightening the float. The stock is a primary focus for traders watching for volatility around earnings, with many pointing to the setup's structural similarities to previous high-profile squeeze plays.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is rallying as investors react to headlines regarding a potential diplomatic framework between the U.S. and Iran, with the community actively debating whether this is a legitimate breakthrough or another recurring market-pumping tactic. While some participants are leaning into bullish momentum driven by the prospect of reopened shipping routes and lower energy costs, many remain skeptical of the news and are closely monitoring technical resistance levels for signs of a potential reversal.

Amplify ETF Trust - Amplify Junior Silver Miners ETF

Amplify Junior Silver Miners ETF

Amplify Junior Silver Miners ETF (SILJ) is trending as community members closely monitor whether the sector will finally see a violent 'catch-up' rally to match the historic price appreciation in physical silver. While some investors argue that juniors are heavily undervalued relative to spot prices and represent a 'coiled spring' ahead of upcoming earnings reports, others are exercising caution due to continued price volatility and the persistent underperformance of miners compared to the underlying metal.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending as investors weigh the company's strong recent revenue growth and expanding sales force against a broader pullback in biotech stocks. The community is actively discussing the upcoming April 30 PDUFA date for the potential approval of Auvelity in treating Alzheimer's disease agitation, which is widely viewed as a major catalyst for future growth.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

Disney is trending as investors react to the company's fiscal second-quarter results, which showcased resilience in streaming margins and theme park performance despite a broader market focus on leadership changes and ongoing cost-restructuring efforts. The community is actively debating the stock's long-term growth potential and turnaround narrative, with sentiment split between those optimistic about margin expansion under new leadership and those skeptical of the company's valuation and cultural direction.

Shoals Technologies Group, Inc. engages in the provision of electrical balance of system solutions for solar energy projects. Its EBOS components include cable assemblies, inline fuses, combiners, disconnects, recombiners, wireless monitoring systems, junction boxes, transition enclosures and splice boxes. The company was founded by Dean Solon in November 1996 and is headquartered in Portland, TN.

Shoals Technologies Group Inc - Ordinary Shares - Class A

Shoals Technologies Group is experiencing heightened investor scrutiny as shareholders navigate a volatile period characterized by ongoing legal proceedings and concerns over management's communication. Despite strong institutional ownership and a focus on essential utility-scale solar infrastructure, the stock is facing downward pressure from broader sector headwinds, prompting active community debate over whether current valuation levels present a value opportunity or signal deeper operational risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$AMLX $5.01bid. DAC (dollar average cost) $1.86 (8.12.24). EXIT $10.00. 
UPDATE: Amylyx Pharmaceuticals (AMLX) upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $11

Stockbuyer

StockTwits Web

Amylyx Pharmaceuticals Inc

 $5.01bid. DAC (dollar average cost) $1.86 (8.12.24). EXIT $10.00. 
UPDATE: Amylyx Pharmaceuticals (AMLX) upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $11